Abstract:Human milk oligosaccharides (HMO) are the third most significant solid component in human milk, working in conjunction with other bioactive components. Numerous factors, including secretor status, race, geography, climate, season, maternal nutrition and weight, gestational age, and delivery method, significantly affect the individual HMO levels and distribution among mothers. In addition to strengthening the epithelial barrier, producing immunomodulatory metabolites, and promoting a gut microbiota rich in Bifidobacterium, HMO also help to enhance the gastrointestinal barrier. HMO perform a range of physiological roles, such as possible immune system support, brain growth, and cognitive function. HMO supplementation to infant formula is safe and supports the newborn's healthy growth, with benefits for infection prevention and the makeup of the microbiota. Through a thorough and methodical evaluation of relevant literature, this study investigated the complex interactions between gut microbiota, the immune system, and HMO in neonates. A sizable corpus of recently released original research publications and thorough review papers were examined in the review. SCOPUS, PubMed, and Google Scholar were reliable and strong sources of information. In addition to these, a few more trustworthy sources were consulted. By reading this article, readers will have a clear understanding of how HMO play a crucial role in influencing the dynamics of the gut microbiota and supporting the development of the immune system in newborns. The knowledge gained from these exchanges may help direct measures meant to improve the health of newborns. However, further investigation is necessary to identify certain underlying processes and possible treatment paths. It is unknown if HMO provide an extra clinical advantage over non-human oligosaccharides due to a lack of research comparing the effects of the two. Better study of the variables controlling HMO composition and their functions will assist to comprehend their short- and long-term advantages for Immunity and Healthy Digestive System in Newborn Infants Throughout Life.

Current Advances in Structure–Function Relationships and Dose-Dependent Effects of Human Milk Oligosaccharides

Human Milk Oligosaccharides: A Critical Review on Structure, Preparation, Their Potential As a Food Bioactive Component, and Future Perspectives.

Human milk oligosaccharides and infant gut microbiota: Molecular structures, utilization strategies and immune function

Biology of human milk oligosaccharides: From basic science to clinical evidence

Research Progress on HMOs Interacting with Intestinal Flora to Regulate Infant Immune Function

Gold standard for nutrition: a review of human milk oligosaccharide and its effects on infant gut microbiota

Functional effects of human milk oligosaccharides (HMOs)

Oligosaccharides in human milk: structural, functional, and metabolic aspects

Across the "Sweetest" Properties of Human Breast Milk: Focus on Oligosaccharides

How Far is It from Infant Formula to Human Milk? A Look at the Human Milk Oligosaccharides

Human Milk Oligosaccharides Combine with Bifidobacterium Longum to Form the “golden Shield” of the Infant Intestine: Metabolic Strategies, Health Effects, and Mechanisms of Action

In Love with Shaping You-Influential Factors on the Breast Milk Content of Human Milk Oligosaccharides and Their Decisive Roles for Neonatal Development

The Science of Human Milk Oligosaccharides (HMO) for Developing Immunity and Healthy Digestive System in Newborn Infants Throughout Life

Human Milk Oligosaccharides and Immune System Development

Enzymatic and Chemoenzymatic Synthesis of Human Milk Oligosaccharides and Derivatives.

Recent advances and challenges in microbial production of human milk oligosaccharides

Linking human milk oligosaccharide metabolism and early life gut microbiota: bifidobacteria and beyond

Modifiable and Non-Modifiable Factors That Affect Human Milk Oligosaccharides Composition

Human Milk Oligosaccharides: Their Effects on the Host and Their Potential as Therapeutic Agents

Biosynthesis of human milk oligosaccharides via metabolic engineering approaches: current advances and challenges.

Current Perspective of Sialylated Milk Oligosaccharides in Mammalian Milk: Implications for Brain and Gut Health of Newborns